TGFB1 and pachyonychia congenita: Indeed, antibodies blocking integrins may impair the growth of primary and secondary tumors in models of PC, though the effects exerted by these therapies could also be related to reduced TGF-β-mediated immunosuppression and angiogenesis [62].